Picture of Fusen Pharmaceutical Co logo

1652 — Fusen Pharmaceutical Co Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m+10.52%
3m+15.15%
6m-7.9%
1yr-61.36%
Volume Change (%)
10d/3m-70.98%
Price vs... (%)
52w High-72.7%
50d MA-0.94%
200d MA-38.4%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital4.38%
Return on Equity2.53%
Operating Margin8.52%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueCNYm452.58462.06407.39486.85385.66n/an/a-2.69%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+1.84-9.13-54.62+67.77-55.22n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Fusen Pharmaceutical Co EPS forecast chart

Profile Summary

Fusen Pharmaceutical Co Ltd is a China-based company principally engaged in the provision of Shuanghuanglian series cold medicines. The Company is mainly engaged in research, development, production and sales of Chinese patent drugs and western medicine products for the treatment of cold and fever, cardiovascular diseases and anemia. The Company's main products include small volume injections, oral liquids, tablets, capsules and granules. The Company distributes its products mainly in domestic market.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
January 18th, 2013
Public Since
July 11th, 2018
No. of Employees
1,243
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
764,822,000

1652 Share Price Performance

Upcoming Events for 1652

Similar to 1652

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Guangzhou Baiyunshan Pharmaceutical Holdings Co logo

Guangzhou Baiyunshan Pharmaceutical Holdings Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Canbridge Pharmaceuticals logo

Canbridge Pharmaceuticals

hk flag iconStock Exchange of Hong Kong Limited

FAQ

Or unlock with your email

Or unlock with your email